RxDoctor Payments Data

Kevin Carnahan, DO

Family Medicine · Sandusky, OHNPI 1598253544

Payments from drug & device makers

$274in general payments, 2019–2025

Across 13 payments — averaging $21.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$74
  • AbbVie$70
  • Exact Sciences$48
  • GSK$20
  • Merck$19
  • Organon$18
  • plus $25 from 2 others

What the payments were for

  • Food & beverage$274100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$274 in reported general payments places this provider in the 40th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$200,782
Medicare patients
477
Services billed
2,798

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide143$250,700
EliquisApixaban65$88,044
JardianceEmpagliflozin65$62,809
TrulicityDulaglutide52$61,769
JanuviaSitagliptin Phosphate64$56,587
XareltoRivaroxaban33$39,515
MounjaroTirzepatide28$36,032
FarxigaDapagliflozin Propanediol39$31,504
Breo ElliptaFluticasone/Vilanterol29$19,142
Rosuvastatin Calcium434$9,584
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog24$9,212
Incruse ElliptaUmeclidinium Bromide15$6,552
Atorvastatin Calcium406$6,429
Tresiba Flextouch U-100Insulin Degludec11$5,371
SynthroidLevothyroxine Sodium63$3,752

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$14$62,80965 claims
MerckJanuvia$19$56,58764 claims
AstraZenecaFarxiga$12$31,50439 claims
GSKBreo Ellipta, Incruse Ellipta$20$25,69444 claims
AbbVieSynthroid$70$3,75263 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Sandusky

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →